1 Preconditioning the heart with brief periods of ischaemia induces delayed endothelial protection against reperfusion injury, but the precise mechanisms involved in this endogenous protein are still unclear. Induction of the type II-nitric oxide synthase (iNOS) acts as a mediator of the preconditioning against myocardial infarction and stunning. The present study was designed to assess whether iNOS also contributes to the delayed endothelial protective eects of preconditioning. 2 Rats were subjected to 20 min ischaemia followed by 60 min reperfusion 24 h after sham surgery or preconditioning (one cycle or 2 min ischaemia/5 min reperfusion and two cycles of 5 min ischaemia/5 min reperfusion). At the end of the reperfusion, coronary segments were removed distal to the site of occlusion and mounted in wire myographs. 3 Ischaemia-reperfusion (I/R) decreased the endothelium-dependent relaxations to acetylcholine (maximal relaxations: sham, 66+5%; I/R, 40+1%; P50.05) and this impairment was prevented by preconditioning (maximal relaxation: 61+6%). 4 Administration of N-(3-aminomethyl)benzyl)acetaminide (1400W), a highly selective inhibitor for iNOS, 10 min before prolonged ischaemia did not modify the bene®cial eect of preconditioning (maximal relaxation: 66+5%). 5 These data show that preconditioning induces delayed protection against reperfusion-injury. However, in contrast to the myocytes, these endothelial protective eects of delayed preconditioning do not involve iNOS.
Introduction
In a large variety of species, myocardial ischaemia followed by acute or long-term reperfusion markedly aects coronary endothelial function (Ku, 1982; VanBenthuysen et al., 1987) , and especially endothelial release of nitric oxide NO (Ma et al., 1993; Richard et al., 1994; Kaeer et al., 1996) . Given the essential role of the endothelium and of NO not only as a vasodilator but also as an inhibitor of platelet aggregation (Moncada et al., 1991) and neutrophil adhesion (Kubes et al., 1991) , such an alteration may have important acute and chronic consequences on the coronary vascular wall. Thus, prevention of endothelial dysfunction during reperfusion is an important therapeutic goal.
Preconditioning with brief periods of ischaemia and reperfusion is considered the most potent anti-ischaemic intervention known to date. Several experiments from our group and others have shown that preconditioning, in addition to limiting infarct size, also protects coronary endothelial cells against acute (Richard et al., 1994) , or chronic (Kaeer et al., 1996) reperfusion injury. Recently, a second window of protection, that appears 24 h after preconditioning, has been observed at the level of the endothelial cells (Kaeer et al, 1997) similar to that described in cardiac myocytes (Marber et al., 1993; Kuzuya et al., 1993) . However, the mechanisms of these endothelial protective eects are still unknown. Recent experiments demonstrated that expression of the inducible form of NO synthase (iNOS) played a central role in the protection induced by preconditioning against stunning (Bolli et al., 1997) and infarction (Imagawa et al., 1999; Guo et al., 1999) . However, whether iNOS also contributes to the protective eect of delayed preconditioning at the level of the endothelium has not been evaluated.
To test this hypothesis, we assessed whether the selective inhibitor of iNOS, N-(3-(aminomethyl)benzyl)acetamidine or 1400W (Garvey et al., 1997) aects the endothelial protective eects of delayed preconditioning in a rat model of ischaemiareperfusion.
Methods

Experimental preparation
Experiments were performed in male Wistar rats (Charles River, Saint Aubin les Elbeuf, France), weighing between 300 ± 400 g, which were assigned to six experimental groups (Figure 1) .
On day 1, rats anaesthetized with 50 mg kg 71 of the short acting anaesthetic sodium methohexital administered intraperitoneally. The animals were intubated with a small metal cannula, and mechanically ventilated with room air supplemented with low¯ow oxygen, using a small rodent ventilator (Apelex, Massy, France), at a rate of 75 cycles min 71 and a tidal volume of 1 ml 100 g 71 body weight. A left thoracotomy was performed, and the heart exposed. A 6-0 polypropylene suture was passed around the proximal left coronary artery, and the ends were passed through a small plastic tube to form a snare. Rats from the sham (day 1) groups (groups 1 ± 4) were subjected to sham ischaemia, while rats from the preconditioning groups (groups 5 and 6) were subjected to one cycle of 2 min ischaemia and 5 min of reperfusion, followed by two cycles of 5 min ischaemia separated by 5 min of reperfusion. The rationale for performing an initial 2 min period of occlusion was that reperfusion after such brief ischaemia was not associated with severe arrhythmias (unlike what occurs after 5 min of ischaemia), but was able to prevent the development of reperfusion, arrhythmias after subsequent 5 min periods of occlusion.
After induction of preconditioning or sham ischaemia, the occluder was removed while the coronary suture was left in place, and the chest was closed in three layers (ribs, muscles and skin) using polyester sutures. A plastic catheter connected to a 5 ml syringe was placed in the chest before sewing, and was used to remove air from the chest after closure. The animals were allowed to recover from anaesthesia (usually within 30 min), after which they were returned to their cage for 24 h.
Twenty-four hours after preconditioning or sham ischaemia (day 2), rats were re-anaesthetized, intubated and mechanically ventilated. The chest was reopened and myocardial ischaemia was induced as described above using the suture previously left in place. Animals were subjected to 20 min ischaemia followed by 60 min reperfusion (Richard et al., 1994) . Sham (day 2) animals (groups 1 and 2) were treated identically except that the artery was not occluded.
Animals from groups 2 (sham+1400W), 4 (I/R+1400W) and 6 (PC+1400W) were treated i.v. with 1 mg kg 71 1400W, a selective iNOS inhibitor, 10 min before ischaemia or sham surgery, while rats from groups 1, 3 and 5 received solvent alone.
In vitro vascular studies
Coronary endothelial dysfunction was assessed as described previously (Richard et al., 1994; Kaeer et al., 1996) . Brie¯y, at the end of the experiment, the heart was removed and immediately placed in cold, oxygenated Krebs buer. The left (ischaemic) coronary artery was carefully dissected free under a microscope, and a 1.5 ± 2 mm long segment was taken distal to the site of occlusion and mounted in a small vessel myograph for isometric tension recording (JP Trading, Aarhus, Denmark). Care was taken during the dissection procedure to avoid damage to the endothelium. After mounting, the vessels were allowed to equilibrate for 30 min, and then were progressively stretched and set to a normalized internal diameter (range 250 ± 300 mm at a level of stretch corresponding to 100 mmHg). The normalization procedure was performed as described previously (Mulvany & Halpern, 1977; Richard et al., 1994) . After another 60 min equilibration period, segments were exposed to increasing concentrations of serotonin (10 78 ± 10 75 M) which is not associated in this rat coronary preparation with the release of endothelium-derived relaxing factors, and thus only induces direct smooth muscle contraction (Nyborg & Mikkelsen, 1990) . Vessels were then washed, and concentration-response curves to acetylcholine (10 78 ± 3.10 75 M) or the NO donor 3-morpholinosydnonimine-Nethylcarbamide SIN-1 (10 78 to 3610 75 M) were studied in each ring after precontraction by serotonin. The contractions to serotonin were then repeated in the presence of
75 M), a non-selective inhibitor of NO synthases.
In vivo eciency of 1400W
To assess the eciency of 1400W in vivo, rats were anaesthetized with 25 mg kg 71 of sodium thiopental, intubated and ventilated as described above. They were then subjected to i.v. injection of lipopolysaccharide (LPS) 3 mg kg 71 (Garvey et al., 1997) and systemic blood pressure was monitored during 3 h (right carotid artery). At this time, animals were divided into two groups, one treated with 1 mg kg 71 1400W i.v. (Garvey et al., 1997) while the other received solvent alone (control), after which systemic blood pressure was monitored for another 90 min, corresponding to the time necessary to perform the infarct protocol. Preconditioning was performed by occlusion of the artery for 2 min followed by 5 min reperfusion, and two periods of 5 min occlusion separated by 5 min reperfusion. All animals were left 24 h before the infarct protocol was performed. This consisted of 20 min coronary occlusion followed by 60 min reperfusion. N-(3-(aminomethyl)benzyl)acetaminide (1400W) was given 10 min before the infarct coronary occlusion.
Statistical analysis
All results are expressed as mean+s.e.mean. In all in vitro experiments, n refers to the number of animals from which the arteries were taken. Contractions to serotonin are expressed in milliNewtons (mN) or as a percentage of the maximal response. Relaxations to acetylcholine or SIN-1 are expressed as a percentage of the contractions. In addition, the negative logarithm of the concentration of agonist causing either 50% inhibition of the contraction to serotonin (IC 50 ; in the case of relaxations) or 50% of the maximal contractile response (EC 50 ; in the case of contractions) was calculated from concentrationresponse curves after adjusting to a sigmoidal curve, using a curve ®tting software (Origin, MicroCal-Software, Inc., Northampton, MA, U.S.A.), and the mean+s.e.mean of these values are presented. Systemic blood pressure was expressed in mmHg.
Contractile or relaxing responses and systemic blood pressure values were compared using a 1-way ANOVA followed when ANOVA was signi®cant by a Tukey test for multiple comparisons. A P value 40.05 was considered statistically signi®cant.
Results
Normalized vessels diameters and contractile responses to serotonin
The normalized internal diameters are shown in Table 1 . There were no signi®cant dierences between the groups.
The responses to increasing concentrations of serotonin are shown in Figure 2 . No signi®cant dierences at each concentration of serotonin were observed between the six groups. EC 50 also did not dier signi®cantly (Table 1) .
The eects of the nonselective NOS inhibitor L-NA (10 75 M) on the contractile responses to serotonin are shown in Table 2 . L-NA signi®cantly increased the contractile responses to 3.10 76 M serotonin in groups sham, I/R, PC and PC+1400W, and to 10 75 M serotonin in all groups (P50.05). However, the eect of L-NA on contraction was not dierent between the six experimental groups (P40.05).
Relaxing responses to SIN-1
The relaxing responses induced by increasing concentrations of the NO donor SIN-1 are shown in Figure 3 , while the IC 50 values are shown in Table 1 . In all groups, SIN-1 induced concentration-dependent relaxations that reached 100% at highest concentration. Ischaemia-reperfusion did not signi®-cantly aect the responses to SIN-1 at any concentration (P40.05), although there was a tendency to a decreased response both in the absence and the presence of 1400W. 
Relaxing responses to acetylcholine
In coronary arteries isolated from sham operated animals, acetylcholine induced concentration-dependent relaxations that reached 66+5% at the highest dose (Figure 4 ). Compared with sham operated animals, the response to acetylcholine was markedly reduced in arteries taken from animals subjected to ischaemia and reperfusion (maximal response: 40+1%; P50.01; Figure 4 ). The impaired response to acetylcholine after ischaemia-reperfusion was signi®cantly prevented by preconditioning performed 24 h before prolonged ischaemia (maximal response: 61+6%, P50.05 vs I/R; Figure 4 ). The improvement of the response to acetylcholine by preconditioning was not modi®ed by the administration of the iNOS inhibitor 1400W 10 min before ischaemia-reperfusion. Indeed, the maximal response to acetylcholine was 61+6% and 66+5% in arteries taken from preconditioned rats in the absence or the presence of 1400W, respectively ( Figure 5 ).
In addition, administration of 1400W had no eects on relaxing responses in sham rats (untreated 66+5%; 1400W 66+5%) or in rats subjected to ischaemia-reperfusion without preconditioning (untreated: 40+1%, 1400W: 44+4%; Figure  5 ).
In vivo eciency of 1400W
After administration of LPS, and before administration of 1400W, mean arterial blood pressure decreased to the same extent in the untreated group (from 145+4 mmHg to 120+3 mmHg) and in the 1400W-treated group (from 136+3 mmHg to 111+4 mmHg; Figure 6 ). Treatment with 1400W was associated with a maintenance of arterial blood pressure (115+4 mmHg) while blood pressure further decreased in the absence of 1400W (88+7 mmHg, P50.05 vs 1400W-treated). The maintenance of arterial blood pressure observed in the treated group con®rms the ecacy of 1400W as an inhibitor of iNOS in our experimental conditions. 
Discussion
The major ®nding of our study, performed in a rat model of myocardial ischaemia-reperfusion is that administration of the selective inhibitor of iNOS 1400W did not aect the endothelial protective eects of delayed preconditioning. This suggests that the mechanisms of the endothelial protection by delayed preconditioning dier from those operating at the level of the myocyte.
In the present experiments, we found that ischaemiareperfusion impaired the relaxing responses to acetylcholine, in agreement with our previous results (Richard et al., 1994; Kaeer et al., 1997) . Ischaemia-reperfusion also moderately impaired the sensitivity of the isolated coronary arteries to a NO donor, suggesting a moderate alteration of the responsiveness of the smooth muscle cells to NO. Moreover, we found that preconditioning the heart with brief episodes of coronary occlusion 24 h before prolonged ischaemia signi®-cantly improved the impaired endothelium-dependent relaxation, also in agreement with our previous results (Kaeer et al., 1997) .
Among the possible mediators of delayed preconditioning, iNOS has been shown to play an important role in several studies. Indeed, brief periods of ischaemia followed by reperfusion have been shown to trigger the expression of iNOS in rabbit hearts . Moreover, inhibition of iNOS by the nonselective inhibitor aminoguanidine induced a loss of the bene®cial eect of delayed preconditioning against myocardial stunning (Bolli et al., 1997) and abolished the infarct size limitation (Imagawa et al., 1999) . Finally, the myocardial protective eects of delayed preconditioning are lost in iNOS ± knockout mice (Guo et al., 1999) .
The present study was designed to assess whether a similar role of iNOS in mediating delayed preconditioning could be found at the level of endothelium. In our experiments, we used the selective iNOS inhibitor 1400W, rather than aminoguanidine, because it is 5000 fold selective for iNOS versus eNOS (Garvey et al., 1997) whereas aminoguanidine is less selective and can aect other enzymatic systems such as catalase (Ou & Wol, 1993) and has direct scavenging activities against hydroxyl radicals (Courderot-Masuyer et al., 1999) . With the use of this selective iNOS inhibitor, we demonstrated for the ®rst time that, in contrast to myocardial cells, iNOS is not involved in the delayed phase of preconditioning in endothelial cells, suggesting that the mechanisms of cytoprotection dier in these two cellular types.
One possible for explaining this lack of eect would be to consider that 1400W did not eectively block iNOS activity. To rule out this hypothesis, we performed experiments to assess the in vivo eciency of 1400W in our experimental conditions. 1400W prevented the delayed hypotension induced by administration of LPS, which is considered to be dependent on iNOS induction. Ecacy of 1 mg kg 71 1400W as an inhibitor of iNOS in rats has also been demonstrated by Garvey et al. (1997) who showed that this dose completely abolished the delayed vascular leakage in the ileum in response to LPS, which is also considered to be dependent on iNOS. Finally, in other experiments from our group, we showed that 1 mg kg 71 1400W was able to prevent the iNOS-mediated decrease in contractility of isolated mesenteric arteries after haemorrhagic shock (Savoye et al., 1998) . Moreover, in all these studies, the capacity of 1400W to inhibit iNOS was assessed at least 1 h after administration, suggesting that the inhibition was long lasting, and covered the full period of ischaemia-reperfusion in our experiments. Thus, these data from our group and others rule out the hypothesis that the lack of eect of 1400W in our experiments is due to an insucient blockade of iNOS.
One likely explanation for the dierences between our results and those obtained previously on infarct size and myocardial stunning could be related to the dierent cell types considered, and to the dierent eects of NO in cardiac myocytes and in endothelial cells. iNOS is induced in blood vessels by in¯ammatory stimuli and produces high concentrations of NO (Stoclet et al., 1998) . In cardiomyocytes, such high levels of NO probably induce a decrease in the metabolic requirements together with decreased oxygen consumption, and this eect is probably responsible for the anti-ischaemic role of iNOS. Contrary to cardiac myocytes, it is unlikely that NO signi®cantly regulates oxygen consumption in endothelial cells. In these cells, an overproduction of NO may have deleterious consequences. Indeed, high concentrations of NO may react with oxygen-derived free radicals to produce highly reactive intermediates such as peroxynitrites or hydroxyl radicals, and may in fact act as a pro-in¯ammatory stimulus. The potential deleterious eects of iNOS induction on endothelial cells has been demonstrated in other experiments from our group: indeed, in a model of haemorrhagic shock, characterized by an increased iNOS expression, we found that treatment with 1400W improved the impaired endothelium-dependent relaxations of mesenteric arteries (Savoye et al., 1998) .
A dissociation between the role of iNOS in myocytes versus endothelial cells has already been demonstrated with the preconditioning ± mimetic monophosphoryl lipid A (MLA) (Nelson et al., 1991; Baxter et al., 1996; Elliott, 1996) . Indeed, recent experiments showed that the infarct size limiting eect of MLA could be abolished by aminoguanidine (Zhao et al., 1997) . Moreover, MLA fails to limit infarct size in iNOS knockout mice (Xi et al., 1999) . In contrast, experiments from our group showed that the delayed endothelial protective eect of MLA did not involve iNOS since it could not be abolished by aminoguanidine (Richard et al., 1999) . Similarly, in mouse heart, the inhibitor of iNOS, S-methylisothiourea, blocks the infarct size limiting eect of MLA but fails to aect its bene®cial eect on post-ischaemic recovery of coronary blood¯ow (Xi et al., 1999) , again suggesting a dissociation between mechanisms of the vascular and myocardial eects of MLA.
Our experiments rule out the hypothesis of a role of iNOS in the endothelial eects of delayed preconditioning, but do not exclude a role of NO produced by other enzymes such as eNOS. Indeed, endogenous stimulation of eNOS (for example by acetylcholine) may exert marked endothelial protective eects after ischaemia and reperfusion (Richard et al., 1995) . Moreover, brief ischaemia induces a delayed increase in the coronary¯ow response to two endotheliumdependent vasodilators, acetylcholine and bradykinine, which release NO through activation of eNOS (Kim et al., 1997) . Whether changes in eNOS contribute to the eect of preconditioning in our present experimental conditions is unknown and is dicult to test because in vivo blockade of eNOS leads to a marked inhibition of endotheliumdependent relaxations in vitro in all experimental groups. In addition, our experiments do not rule out the hypothesis that iNOS might play a role earlier in the time course of delayed preconditioning (i.e.`trigger' eect). Whether iNOS is a trigger of the delayed endothelial protective eects of preconditioning remains to be determined.
Conclusion
Our experiments demonstrate that delayed preconditioning protects coronary endothelial cells against ischaemia-reperfusion injury in the rat. However, in contrast to the protective eects at the level of the myocytes, the endothelial protective eects of delayed preconditioning do not appear to involve inducible NO synthase. Further studies are required to identify the precise mechanisms responsible for the endothelial protective eects of delayed preconditioning.
